<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001297'>Strokes</z:hpo> due to <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> are the most prominent <z:e sem="disease" ids="C0027765" disease_type="Disease or Syndrome" abbrv="">neurological disease</z:e> affecting adults, and efforts to reduce <z:hpo ids='HP_0001297'>stroke</z:hpo> occurrence, in addition to <z:hpo ids='HP_0001297'>stroke</z:hpo>-risk reduction, will require insights into molecular mechanisms </plain></SENT>
<SENT sid="1" pm="."><plain>Our studies showing <z:mp ids='MP_0005266'>abnormal metabolism</z:mp> of low and <z:chebi fb="6" ids="39025">high density lipoproteins</z:chebi> (<z:chebi fb="15" ids="39026">LDL</z:chebi> and <z:chebi fb="17" ids="39025">HDL</z:chebi>) in vivo and of RFLP in <z:chebi fb="0" ids="13850">apoprotein</z:chebi> AI, the major protein of <z:chebi fb="17" ids="39025">HDL</z:chebi>, in <z:hpo ids='HP_0001297'>stroke</z:hpo>-prone subjects suggest that greater exploration of fundamental mechanisms of atherothrombotic <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> (ABI) should yield preventative strategies, the ultimate treatment for <z:hpo ids='HP_0001297'>strokes</z:hpo> </plain></SENT>
</text></document>